Add to ORKGBackground Prior to the era of immunomodulating or immunosuppressive (IS) treatments Multiple Sclerosis (MS) was linked to reduced rates of cancer. Method A descriptive study of MS patients with a documented oncological event was performed
Background: Data on cancer prevalence and incidence in multiple sclerosis (MS) patients are controve...
International audienceBackground: Studies of cancer prevalence have produced conflicting results con...
International audienceBackground: Studies of cancer prevalence have produced conflicting results con...
International audienceBACKGROUND: Prior to the era of immunomodulating or immunosuppressive (IS) tre...
International audienceBACKGROUND: Prior to the era of immunomodulating or immunosuppressive (IS) tre...
International audienceBACKGROUND: Prior to the era of immunomodulating or immunosuppressive (IS) tre...
Background: The association between multiple sclerosis (MS) and cancer has long been investigated wi...
Background: The association between multiple sclerosis (MS) and cancer has long been investigated wi...
Abstract Background The association between multiple sclerosis (MS) and cancer has long been investi...
Background: Multiple sclerosis (MS), a central nervous system (CNS) autoimmune disorder, affects 2.3...
Cancer occurrence in patients with multiple sclerosis (MS) has been little studied, but associations...
Background Studies of cancer prevalence have produced conflicting results concerning the relative ri...
Multiple sclerosis (MS) is a chronic inflammatory disease of central nervous system (CNS) which is s...
<div><p>Background</p><p>Studies of cancer prevalence have produced conflicting results concerning t...
Background Whether disease-modifying therapies (DMTs) influence cancer in multiple sclerosis (MS) i...
Background: Data on cancer prevalence and incidence in multiple sclerosis (MS) patients are controve...
International audienceBackground: Studies of cancer prevalence have produced conflicting results con...
International audienceBackground: Studies of cancer prevalence have produced conflicting results con...
International audienceBACKGROUND: Prior to the era of immunomodulating or immunosuppressive (IS) tre...
International audienceBACKGROUND: Prior to the era of immunomodulating or immunosuppressive (IS) tre...
International audienceBACKGROUND: Prior to the era of immunomodulating or immunosuppressive (IS) tre...
Background: The association between multiple sclerosis (MS) and cancer has long been investigated wi...
Background: The association between multiple sclerosis (MS) and cancer has long been investigated wi...
Abstract Background The association between multiple sclerosis (MS) and cancer has long been investi...
Background: Multiple sclerosis (MS), a central nervous system (CNS) autoimmune disorder, affects 2.3...
Cancer occurrence in patients with multiple sclerosis (MS) has been little studied, but associations...
Background Studies of cancer prevalence have produced conflicting results concerning the relative ri...
Multiple sclerosis (MS) is a chronic inflammatory disease of central nervous system (CNS) which is s...
<div><p>Background</p><p>Studies of cancer prevalence have produced conflicting results concerning t...
Background Whether disease-modifying therapies (DMTs) influence cancer in multiple sclerosis (MS) i...
Background: Data on cancer prevalence and incidence in multiple sclerosis (MS) patients are controve...
International audienceBackground: Studies of cancer prevalence have produced conflicting results con...
International audienceBackground: Studies of cancer prevalence have produced conflicting results con...